Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandru Tatomir

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|November 8, 2019
JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic responseFreidrich Anselmo, Alexandru Tatomir, Dallas Boodhoo, et al.
Immunologic Research|November 9, 2017
The complement system as a biomarker of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Anamaria Talpos-Caia, Freidrich Anselmo, et al.
Immunologic Research|June 21, 2015
The role of complement activation in atherogenesis: the first 40 yearsSonia I Vlaicu, Alexandru Tatomir, Violeta Rus, et al.
Frontiers in Immunology|April 25, 2020
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in OligodendrocytesAlexandru Tatomir, Gautam Rao, Dallas Boodhoo, et al.
Frontiers in Immunology|July 12, 2024
Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Freidrich Anselmo, Dallas Boodhoo, et al.
Clinical Immunology (Orlando, Fla.)|April 24, 2022
RGC-32' dual role in smooth muscle cells and atherogenesisSonia I Vlaicu, Alexandru Tatomir, Matthew Fosbrink, et al.
Frontiers in Immunology|February 11, 2021
RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune EncephalomyelitisAlexandru Tatomir, Austin Beltrand, Vinh Nguyen, et al.
Frontiers in Immunology|August 16, 2021
RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive AstrocytosisAlexandru Tatomir, Austin Beltrand, Vinh Nguyen, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2024
RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney diseaseAlexandru Tatomir, Sonia Vlaicu, Vinh Nguyen, et al.
Experimental and Molecular Pathology|January 23, 2017
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosisDaniel Hewes, Alexandru Tatomir, Adam M Kruszewski, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|November 8, 2019
JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic responseFreidrich Anselmo, Alexandru Tatomir, Dallas Boodhoo, et al.
Immunologic Research|November 9, 2017
The complement system as a biomarker of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Anamaria Talpos-Caia, Freidrich Anselmo, et al.
Immunologic Research|June 21, 2015
The role of complement activation in atherogenesis: the first 40 yearsSonia I Vlaicu, Alexandru Tatomir, Violeta Rus, et al.
Frontiers in Immunology|April 25, 2020
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in OligodendrocytesAlexandru Tatomir, Gautam Rao, Dallas Boodhoo, et al.
Frontiers in Immunology|July 12, 2024
Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Freidrich Anselmo, Dallas Boodhoo, et al.
Clinical Immunology (Orlando, Fla.)|April 24, 2022
RGC-32' dual role in smooth muscle cells and atherogenesisSonia I Vlaicu, Alexandru Tatomir, Matthew Fosbrink, et al.
Frontiers in Immunology|February 11, 2021
RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune EncephalomyelitisAlexandru Tatomir, Austin Beltrand, Vinh Nguyen, et al.
Frontiers in Immunology|August 16, 2021
RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive AstrocytosisAlexandru Tatomir, Austin Beltrand, Vinh Nguyen, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2024
RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney diseaseAlexandru Tatomir, Sonia Vlaicu, Vinh Nguyen, et al.
Experimental and Molecular Pathology|January 23, 2017
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosisDaniel Hewes, Alexandru Tatomir, Adam M Kruszewski, et al.
Pageof 3